Naveed Ejaz
About Naveed Ejaz
Naveed Ejaz is the Director of Digital Therapies at MindMaze, where he has worked since 2018. He holds a PhD in Neurobiology from Imperial College London and has extensive experience in research and technology across various institutions.
Current Role at MindMaze
Naveed Ejaz serves as the Director of Digital Therapies at MindMaze, a position he has held since 2018. In this role, he focuses on developing innovative digital therapy solutions that integrate neuroscience with technology. His work contributes to advancing therapeutic options for patients with neurological conditions. MindMaze is known for its commitment to harnessing technology to improve patient outcomes.
Educational Background
Naveed Ejaz has a robust educational background in the fields of neurobiology, computational biology, and mathematics. He earned his Doctor of Philosophy (PhD) in Neurobiology and Neurosciences from Imperial College London, where he studied from 2006 to 2012. Prior to that, he obtained a Master of Philosophy (MPhil) in Computational Biology from the University of Cambridge in 2006. His undergraduate studies culminated in a Bachelor of Science (BS) in Mathematics and Computer Science from Lahore University of Management Sciences, completed in 2004.
Previous Work Experience
Before joining MindMaze, Naveed Ejaz accumulated diverse experience in research and engineering. He worked as a System Engineer at Alchemy Technologies in Karachi, Pakistan, from 2004 to 2005. He then served as a Postdoctoral Researcher at UCL from 2012 to 2015 and at Western University from 2015 to 2018. Additionally, he was a Visiting Researcher at Johns Hopkins Medicine for two months in 2017, where he engaged in advanced research initiatives.
Research Contributions
Throughout his career, Naveed Ejaz has contributed to various research projects focused on neurobiology and digital therapies. His postdoctoral roles at UCL and Western University allowed him to engage in significant research activities that furthered understanding in his field. His work has implications for the development of digital therapeutic solutions, enhancing treatment methodologies for neurological disorders.